Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine disorders

L D Hordon1, V Wright

  • 1University of Leeds, UK.

Current Opinion in Rheumatology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Endocrine disorders impact bone mass, with thyroid issues potentially reducing bone density. While diabetes is linked to osteopenia, some studies show increased bone mass, though it may impair bone formation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT.

Bone·2005
Same author

Soil-transmitted nematode infections and mebendazole treatment in Mafia Island schoolchildren.

Annals of tropical medicine and parasitology·2003
Same author

Lipoatrophic-lipodystrophic syndromes: the spectrum of findings on MR imaging.

AJR. American journal of roentgenology·2002
Same author

Bone microarchitecture in osteoporotic men: universal or corticosteroid dependent?

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2001
Same author

A single blind, prospective, randomized trial comparing n-butyl 2-cyanoacrylate tissue adhesive (Indermil) and sutures for skin closure in hand surgery.

Journal of hand surgery (Edinburgh, Scotland)·2001
Same author

The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells.

Bone·2001
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Connective Tissue Disorders

Background:

  • The relationship between endocrine disorders and bone mass is a growing area of research.
  • Existing literature suggests varying effects of conditions like thyroid disease, diabetes mellitus, primary hyperparathyroidism, and acromegaly on bone density.
  • The interplay between endocrine function, bone health, and connective tissue integrity requires further elucidation.

Purpose of the Study:

  • To review the current understanding of how specific endocrine disorders influence bone mass.
  • To examine the potential impact of thyroid disorders, diabetes mellitus, primary hyperparathyroidism, and acromegaly on bone metabolism.
  • To discuss the association between thyroid disease, connective tissue disorders, and the role of androgens.

Main Methods:

Related Experiment Videos

  • Literature review and synthesis of existing studies on endocrine disorders and bone mass.
  • Analysis of findings related to bone density in hyperparathyroidism, diabetes mellitus, and acromegaly.
  • Discussion of the pathogenesis of connective tissue diseases in the context of endocrine dysfunction.

Main Results:

  • Thyroid disorders, not thyroxine replacement, may be linked to reduced bone mass.
  • Fracture rates in diagnosed primary hyperparathyroidism do not seem elevated.
  • Diabetes mellitus shows conflicting results regarding bone mass, but may negatively affect bone formation and calcium excretion.
  • Acromegaly patients, despite hypogonadism, do not exhibit osteopenia.

Conclusions:

  • The impact of endocrine disorders on bone mass is complex and condition-specific.
  • Further research is needed to clarify the mechanisms underlying bone alterations in endocrine diseases.
  • Understanding these associations is crucial for managing bone health in patients with endocrine disorders.